Pancreatic Cancer Research

ResearcherUniversity of Pittsburgh Medical CenterNo recent work listed

Colin Eamon Champ

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1879-7463; OpenAlex author ID A5068711519. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper

Papers 3

  1. The Impact of Serum Glucose in the Treatment of Locoregionally Advanced Pancreatic Cancer. Last author DOI 10.1097/coc.0000000000000580↗
  2. Targeting Tumor Metabolism With Statins During Treatment for Advanced-stage Pancreatic Cancer. Last author DOI 10.1097/coc.0000000000000433↗
  3. Conditional survival probabilities for patients with resected pancreatic adenocarcinoma. First author DOI 10.1097/coc.0b013e31826c62b7↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nick A. Iarrobino · 2 shared papers, 2018–2019 · strength 0.23
  2. Mark Vikas Mishra · 2 shared papers, 2014–2018 · strength 0.15
  3. Voichita Bar‐Ad · 1 shared paper, 2014 · strength 0.05
  4. Scott W. Keith · 1 shared paper, 2014 · strength 0.05
  5. Yaacov Richard Lawrence · 1 shared paper, 2014 · strength 0.05
  6. Timothy Norman Showalter · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.